Machine learning to predict waitlist dropout among liver transplant candidates with hepatocellular carcinoma

Allison Kwong1, Bilal Hameed2, Shareef Syed3

  • 1Division of Gastroenterology and Hepatology, Stanford University, Stanford, USA.

Cancer Medicine
|January 14, 2022
PubMed

Insights

Predicting waitlist dropout for liver transplant candidates with hepatocellular carcinoma (HCC) is now simpler. A new 5-variable model accurately forecasts dropout risk, aiding transplant prioritization for HCC patients.

Area of Science:

  • Hepatology
  • Transplant Surgery
  • Oncology

Background:

  • Accurate outcome prediction for liver transplant candidates with hepatocellular carcinoma (HCC) is difficult.
  • A novel prediction model was developed to identify patients at risk of waitlist dropout.

Purpose of the Study:

  • To develop and validate a predictive model for waitlist dropout in liver transplant candidates diagnosed with HCC.
  • To improve patient prioritization for liver transplantation.

Main Methods:

  • Utilized data from 18,920 adult liver transplant candidates in the US listed with HCC.
  • Employed random forest and Cox proportional hazards models, analyzing 1,181 variables.
  • Identified 5 key predictive variables: AFP, tumor size, bilirubin, INR, and ascites.

Main Results:

  • A 5-variable model identified 12 predictive features for waitlist dropout.
  • The final Cox model achieved a concordance statistic of 0.74 in the validation set.
  • An online calculator is available for clinical application: http://hcclivercalc.cloudmedxhealth.com/.

Conclusions:

  • A simple, interpretable 5-variable model effectively predicts 3-, 6-, and 12-month waitlist dropout in HCC patients.
  • This model aids in prioritizing HCC patients based on their transplant urgency.
  • The tool can enhance clinical decision-making for liver transplant allocation.
Abstract